BRAT1 and neoplasm: Our data reveals that the pro-migratory, pro-invasive phenotype of BRAT1-proficient tumors can be effectively curtailed by CurD, with significantly reduced numbers of brain-penetrating GSCs in the tumor microenvironment following treatment.